In cisplatin-resistant HCC, METTL3 overexpression elevates m6A levels on NFE2L2 mRNA transcripts, enhancing their stability and thereby suppressing ferroptosis [195]. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.